HbA1c Prediction Using CGM Image Encoding and Few-Shot Learning

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for predicting HbA1c levels are reactive and lack accuracy, failing to provide proactive management strategies for diabetes, especially due to the complexity of integrating short-term blood glucose monitoring data effectively.

Innovation Solution

Conversion of time series continuous glucose monitoring (CGM) sensor data into binary and histogram images, followed by convolutional neural network (CNN) based few-shot learning (FSL) for feature extraction, utilizing a novel normalized FSL-distance (FSLD) metric, and a k-nearest neighbor (KNN) model with majority voting for advanced HbA1c level prediction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional estimation methods (DCCT, ADAG studies) are used to predict HbA1c from plasma glucose values, then the prediction can be obtained, but the accuracy is limited with R2 scores ranging from 0.71 to 0.84

Engineering Contradiction:
ImproveHbA1c prediction accuracyVSAvoidmodel complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent transforms time-series CGM data into image representations (spatial domain), enabling the application of CNN-based few-shot learning methods that were not previously applicable to glucose data. This dimensional transformation from temporal to spatial representation allows for more accurate feature extraction and achieves R2 scores exceeding 0.85, resolving the accuracy limitation of traditional methods.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent replaces traditional statistical estimation methods (DCCT, ADAG) with a deep learning approach using CNN and few-shot learning algorithms. This substitution of the prediction mechanism enables the system to learn complex non-linear relationships in glucose data, achieving superior accuracy (R2 > 0.85) compared to the R2 scores of 0.71-0.84 from traditional methods.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Loss of time

If short-term CGM data is used for prediction, then proactive diabetes management is enabled, but the complexity of integrating and analyzing the time series data increases

Engineering Contradiction:
Improveprediction lead timeVSAvoiddata processing complexity
Core Design Contradiction:
Loss of timeVSDevice complexity

Solution Approach 1:

By converting time-series CGM data into image representations, the patent transforms complex temporal patterns into spatial features that CNNs can process efficiently. This transformation simplifies the integration and analysis of short-term glucose data, enabling proactive prediction while managing the complexity through dimensionality transformation rather than direct temporal analysis.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent introduces image representation as an intermediary between raw CGM data and the prediction model. This intermediate spatial representation serves as a bridge that simplifies the processing of time-series data, allowing the CNN-based few-shot learning model to extract meaningful features without directly handling the complexity of raw temporal glucose measurements.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If conventional HbA1c monitoring is performed, then current glucose levels are assessed, but the ability to predict future HbA1c levels and enable proactive management is lost

Engineering Contradiction:
Improvediabetes management effectivenessVSAvoidfuture HbA1c prediction accuracy
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The patent enables preliminary prediction of future HbA1c levels by analyzing short-term CGM data patterns. The CNN-based few-shot learning model forecasts upcoming HbA1c values before they are actually measured, allowing proactive diabetes management interventions. This preliminary action transforms reactive monitoring into predictive management, improving reliability by enabling early corrective measures.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements a feedback mechanism where predicted future HbA1c levels are compared with actual measurements to continuously improve the model. This feedback loop enhances both the prediction accuracy and the overall effectiveness of diabetes management by learning from the discrepancies between predicted and actual outcomes, thereby improving reliability over time.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12500002B2Long term HbA1c prediction
Publication Date: 2025.12.16 SIDRA MEDICAL & RES CENT
  • US12500002B2 patent drawing
  • US12500002B2 patent drawing
  • US12500002B2 patent drawing

AI summary

Provided are methods of predicting HbA1c values.